Competitive ELISA studies of neural thread protein in urine in Alzheimer's disease
Authors:
- 23 January 2007
- journal article
- research article
- Published by Wiley in Journal of Clinical Laboratory Analysis
- Vol. 21 (1) , 24-33
Abstract
A specific and reliable competitive affinity assay kit has been developed to quantitatively measure neural thread protein (NTP) in first morning urine samples. This assay, called the urine neural thread protein test (UNTP), is a competitive enzyme‐linked immunosorbent assay (ELISA) format affinity assay using 32‐well microtiter plates. The assay detects UNTP in the 10–60 µg/mL range (an improvement over earlier assays of 103 × ), is linear and more reproducible (average coefficient of variation [CV] 6.2% in precision studies).The utility of the assay has been demonstrated in urine samples from patients with Alzheimer's disease (AD) and controls (sensitivity of 90% and specificity of 91%). Test–retest assays of subjects with AD and controls were comparatively stable at intervals of 2 days to 4.5 years, which suggests that positive (elevated) or negative (normal) NTP levels do not fluctuate significantly over time with respect to the cutoff. J. Clin. Lab. Anal. 21:24–33, 2007.Keywords
This publication has 31 references indexed in Scilit:
- Amyloid β Protein in Plasma as a Diagnostic Marker for Alzheimer’s DiseaseNeurobiology of Aging, 1998
- Biochemical Diagnostic Markers to Detect Early Alzheimer’s DiseaseNeurobiology of Aging, 1998
- Characterization of the AD7C-NTP cDNA expression in Alzheimer's disease and measurement of a 41-kD protein in cerebrospinal fluid.Journal of Clinical Investigation, 1997
- Tau in cerebrospinal fluid: A potential diagnostic marker in Alzheimer's diseaseAnnals of Neurology, 1995
- Reduction of β‐amyloid peptide42 in the cerebrospinal fluid of patients with Alzheimer's diseaseAnnals of Neurology, 1995
- Tau protein concentrations in cerebrospinal fluid of patients with dementia of the Alzheimer type.Journal of Neurology, Neurosurgery & Psychiatry, 1995
- Cerebrospinal fluid levels of amyloid β‐protein in alzheimer's disease: Inverse correlation with severity of dementia and effect of apolipoprotein e genotypeAnnals of Neurology, 1995
- Concentrations of amyloid β protein in cerebrospinal fluid of patients with alzheimer's diseaseAnnals of Neurology, 1995
- Accuracy of clinical diagnosis of Alzheimer's disease.BMJ, 1990
- Validity of clinical diagnosis in dementia: a prospective clinicopathological study.Journal of Neurology, Neurosurgery & Psychiatry, 1985